Key facts
- Kranus Health’s last known valuation is $24.7M (Jun 2022).
- It has raised $28.0M; the latest was Later Stage VC in Nov 2025.
- Notable investors include High-Tech Gründerfonds, Superangels, A-Round Capital, BaseCamp Ventures, CapHorn Invest — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Kranus Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Kranus Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kranus Health
Operator of a digital health platform intended to help patients lead a better life. The company's platform addresses a broad range of urological conditions, including women's health (incontinence), andrology (erectile dysfunction), and prostate enlargement (BPH) by integrating with both doctors and patients throughout the treatment journey, offering personalized treatments, enabling patients to enhance the quality of life and ensure better health outcomes, backed by clinical (randomized controlled trial) RCT trials with demonstrated proven efficacy in improving patient outcomes.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Founded
- 2020
- Employees
- 66
- Website
- kranushealth.com/
- Ownership
- Privately Held (backing)
Kranus Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kranus Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kranus Health in its N-PORT filings yet. We sweep new filings monthly.